Adrenal Failure Caused by a Retroperitoneal Malignant Mesothelioma

被引：2

作者：

Nomura, Masatoshi ^{[1
]}

Sasano, Hironobu ^{[2
]}

Okada, Yasuyo ^{[3
]}

Watanabe, Tetsuhiro ^{[1
]}

Sakamoto, Shohei ^{[1
]}

Sakiyama, Yumiko ^{[1
]}

Sakamoto, Ryuichi ^{[1
]}

Abe, Ichiro ^{[1
]}

Horiuchi, Toshihiro ^{[1
]}

Yanase, Toshihiko ^{[1
]}

Takayanagi, Ryoichi ^{[1
]}

机构：

[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan

[2] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan

[3] Nakabaru Hosp, Dept Social Insurance, Fukuoka, Japan

来源：

INTERNAL MEDICINE | 2009年 / 48卷 / 24期

关键词：

adrenal failure; retroperitoneal mesothelioma; chemotherapy; PERITONEAL MESOTHELIOMA; EPITHELIAL MESOTHELIOMA; PLEURAL MESOTHELIOMA; THROMBOMODULIN; DIAGNOSIS; CHEMOTHERAPY; COMBINATION; CALRETININ; CISPLATIN;

D O I：

10.2169/internalmedicine.48.2438

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 62-year-old man presented with clinical signs of acute abdominal pain and adrenal insufficiency. Computerized tomographic scans revealed bilateral adrenal tumors and the left adrenal tumor was surgically resected. The patient was found to have retroperitoneal mesothelioma presenting as bilateral metastatic adrenal tumors, which were well controlled by systemic chemotherapy with CDDP and 5-FU. This case appears to be the first reported case in the literature of adrenal failure due to bilateral adrenal infiltration caused by retroperitoneal malignant mesothelioma.

引用

页码：2109 / 2114

页数：6

共 25 条

[1] Malignant peritoneal mesothelioma in women - A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis [J].

Baker, PM ;

Clement, PB ;

Young, RH .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) :724-737

[2] Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis [J].

Berghmans, T ;

Paesmans, M ;

Lalami, Y ;

Louviaux, I ;

Luce, S ;

Mascaux, C ;

Meert, AP ;

Sculier, JP .

LUNG CANCER, 2002, 38 (02) :111-121

[3] Epidemiology of peritoneal mesothelioma: a review [J].

Boffetta, P. .

ANNALS OF ONCOLOGY, 2007, 18 (06) :985-990

[4]

Bridda Alessio, 2007, MedGenMed, V9, P32

[5]

COLLINS CL, 1992, AM J PATHOL, V141, P827

[6] Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma [J].

Comin, CE ;

Novelli, L ;

Boddi, V ;

Paglierani, M ;

Dini, S .

HUMAN PATHOLOGY, 2001, 32 (05) :529-536

[7] Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura [J].

Cury, PM ;

Butcher, DN ;

Fisher, C ;

Corrin, B ;

Nicholson, AG .

MODERN PATHOLOGY, 2000, 13 (02) :107-112

[8] Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma [J].

Green, J. ;

Dundar, Y. ;

Dodd, S. ;

Dickson, R. ;

Walley, T. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)

[9] Mesothelioma and asbestos-related pleural diseases [J].

Greillier, Laurent ;

Astoul, Philippe .

RESPIRATION, 2008, 76 (01) :1-15

[10] Malignant mesothelioma of the tunica vaginalis testis:: a case report and review of the literature [J].

Guney, Nese ;

Basaran, Mert ;

Karayigit, Ebru ;

Muesluemanoglu, Ahmet ;

Guney, Soner ;

Kilicaslan, Isin ;

Gulbarut, Saime .

MEDICAL ONCOLOGY, 2007, 24 (04) :449-452

← 1 2 3 →